Tissue Engineering and Regenerative Medicine 2019:The Role of Biofabrication-A Year in Review by Ramos, Tiago & Moroni, Lorenzo
 
 
 
Tissue Engineering and Regenerative Medicine 2019
Citation for published version (APA):
Ramos, T., & Moroni, L. (2020). Tissue Engineering and Regenerative Medicine 2019: The Role of
Biofabrication-A Year in Review. Tissue Engineering. Part C. Methods , 26(2), 91-106.
https://doi.org/10.1089/ten.tec.2019.0344
Document status and date:
Published: 01/02/2020
DOI:
10.1089/ten.tec.2019.0344
Document Version:
Publisher's PDF, also known as Version of record
Document license:
Taverne
Please check the document version of this publication:
• A submitted manuscript is the version of the article upon submission and before peer-review. There can
be important differences between the submitted version and the official published version of record.
People interested in the research are advised to contact the author for the final version of the publication,
or visit the DOI to the publisher's website.
• The final author version and the galley proof are versions of the publication after peer review.
• The final published version features the final layout of the paper including the volume, issue and page
numbers.
Link to publication
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these
rights.
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
• You may not further distribute the material or use it for any profit-making activity or commercial gain
• You may freely distribute the URL identifying the publication in the public portal.
If the publication is distributed under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license above,
please follow below link for the End User Agreement:
www.umlib.nl/taverne-license
Take down policy
If you believe that this document breaches copyright please contact us at:
repository@maastrichtuniversity.nl
providing details and we will investigate your claim.
Download date: 07 Jan. 2021
METHODS ARTICLE
Tissue Engineering and Regenerative Medicine 2019:
The Role of Biofabrication—A Year in Review
Tiago Ramos, PhD1 and Lorenzo Moroni, PhD2
Despite its relative youth, biofabrication is unceasingly expanding by assimilating the contributions from
various disciplinary areas and their technological advances. Those developments have spawned the range of
available options to produce structures with complex geometries while accurately manipulating and controlling
cell behavior. As it evolves, biofabrication impacts other research fields, allowing the fabrication of tissue
models of increased complexity that more closely resemble the dynamics of living tissue. The recent blooming
and evolutions in biofabrication have opened new windows and perspectives that could aid the translational
struggle in tissue engineering and regenerative medicine (TERM) applications. Based on similar methodologies
applied in past years’ reviews, we identified the most high-impact publications and reviewed the major con-
cepts, findings, and research outcomes in the context of advancement beyond the state-of-the-art in the field. We
first aim to clarify the confusion in terminology and concepts in biofabrication to therefore introduce the
striking evolutions in three-dimensional and four-dimensional bioprinting of tissues. We conclude with a short
discussion on the future outlooks for innovation that biofabrication could bring to TERM research.
Keywords: biofabrication, bioprinting, bioassembly, instructive scaffolds
The Aim and Scope
The field of tissue engineering and regenerativemedicine (TERM) is growing by combining different
disciplinary approaches, including stem cell biology, func-
tional scaffold materials, nanotechnology, and the most recent
additive manufacturing (AM) (commonly known as three-
dimensional [3D] printing). AM methods have also made
great and rapid advancements and are now utilized to produce
structures with complex geometries used in a wide variety of
fields. More importantly for the scope of this review, AM
has made important progress in the production of a series
of constructs designed and used for medical engineering ap-
proaches. AM technology has also been at the foundation of
biofabrication, a quickly growing interdisciplinary field that
has recently been the focus of great attention with significant
updates on its terminology, particularly with the adoption of
biofabrication concepts within the TERM fields. In view
of the potential of biofabrication strategies to impact TERM
applications with the generation of constructs of enhanced
functionality, this article also aims to focus on the most rel-
evant topics related to biofabrication over the last year (or so).
Some excellent reviews1–5 and other ‘‘year in review’’
articles6–8 have been recently published regarding the AM
and biofabrication concepts applied in TERM. Here, we
have adopted similar methods to those used in previous
‘‘year in review’’ articles to select the main topics to be
highlighted. First, we searched on the National Center for
Biotechnology Information (NCBI) database for the key-
words ‘‘biofabrication,’’ ‘‘additive manufacturing,’’ ‘‘bio-
printing,’’ or ‘‘bioassembly’’ and sorted publications from
January 1, 2018 to November 30, 2019. Second, we have
examined previous ‘‘year in review’’ article topics to care-
fully exclude those already discussed. Third, in this review,
we have excluded the extensively reviewed field of cell/
biomaterial interaction, as this is of broader scope than
biofabrication. Fourth and finally, we have selected three
main topics to cover in this review: (1) efforts in clarify-
ing terminology and (2) 3D and (3) four-dimensional (4D)
bioprinting of tissues. For each section, several articles are
used to illustrate the major concepts, findings, and research
outcomes in the context of advancement beyond the state-
of-the-art in the field.
Clarifying Terminology—Biofabrication and Bioinks
Over the last 3 years the ‘‘biofabrication community’’ has
made an important effort to clarify the terminology related
to ‘‘biofabrication’’1–3 and ‘‘bioinks,’’4 mainly for TERM
applications. First coined in 1994,9 ‘‘biofabrication’’ and its
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related terminology have evolved over time in parallel with
the concept of bioprinting. This parallelism has led to con-
fusion in terminology and concepts and in some instances to
a conflation of the two terms. Recent reviews have exten-
sively addressed this matter and reappraised the definition of
these terms.1,3 Biofabrication has been defined by several
groups over the years.9–12 Taking into account the evolv-
ing concepts and the wide panoply of research activities
encompassed in the field of biofabrication, Groll et al.
suggested in 2016 that biofabrication for TERM is ‘‘the
automated generation of biologically functional products
with structural organization from living cells, bioactive mol-
ecules, biomaterials, cell aggregates such as micro-tissues,
or hybrid cell-material constructs, through Bioprinting or
Bioassembly and subsequent tissue maturation processes.’’1
Within biofabrication, therefore, there are two main pillars
distinguished by the length scale of the minimum fabrica-
tion unit: (1) ‘‘bioprinting’’ allows the spatial arrangement
of cells, materials, and biological active factors, in which
the minimum fabrication unit is down to molecular level;
(2) ‘‘bioassembly’’ facilitates the automated assembly of
cell containing building blocks, where the minimum fabri-
cation units are preformed cell-containing building blocks
with sizes large enough so that automated assembly can
technologically be achieved.1 In addition, the fabrication of
3D scaffolds by AM technologies with hierarchical and/or
surface properties able to steer cell activity is to be con-
sidered within biofabrication approaches for TERM appli-
cations when the subsequent maturation process yields a
structural biologically functional construct. Thorough re-
views on the technology and terminology used in biofabri-
cation have recently been published elsewhere.1–3 These
techniques can provide constructs with increasingly high
levels of biomimicry toward getting closer and closer to the
complexity of tissues and organs. More importantly, bio-
fabrication allows for the spatiotemporal modulation of cell/
cell and cell/extracellular matrix (ECM) interaction. The
most commonly used technologies applied in biofabrication
comprise the following: (1) 3D and 4D printing; (2) light-
based technologies, including stereolithography (SLA), two-
photon polymerization (2-PP), and laser-induced hydrogel
degradation; (3) fused deposition modeling (FDM)/3D fiber
deposition/bioextrusion; (4) 3D plotting/bioplotting/robotic
dispensing/extrusion bioprinting; (5) wet-spun automated
extrusion systems; (6) ink-jet and valve-jet bioprinting; and
(7) electrospinning. Here, we aim to focus on the most re-
cent advancements on these technologies and thereafter
address the spatiotemporal resolutions that led to the rise of
4D bioprinting constructs.
First used in 2003, the term bioink was used in the con-
text of bioprinting and was introduced together with the
term biopaper.13,14 The initial concept was to provide a
biopaper (hydrogel) that would be thereafter populated with
living cells and/or tissue spheroids as the ‘‘bioink’’ to be
bioprinted. Therefore, the term bioink originally referred to
the cellular component of the solution that would be posi-
tioned in the 3D in a porous biomaterial (i.e., a scaffold) or
within the hydrogel. In 2018, Williams et al. proposed a
more complicated division of the term bioink in four sub-
categories: support bioinks, fugitive bioinks, structural
bioinks, and functional bioinks.15 In the most recent studies,
and according to the recently updated definition of biofab-
rication,1 bioinks are described as ‘‘a formulation of cells
suitable for processing by an automated biofabrication
technology that may also contain biologically active com-
ponents and biomaterials.’’4 Therefore, cells are the man-
datory component of a bioink, and thus, formulations that
include biologically active components or molecules, but do
not contain any cells, are not qualified as a bioink. Further
distinction between bioinks and biomaterial inks was pro-
posed recently by Groll et al.4 Biomaterial inks were
therefore defined as ‘‘materials that can be printed and
subsequently seeded with cells after printing, but not di-
rectly formulated with cells.’’
3D Bioprinting
Bioprinting is a class of AM processes in which bio-
materials, bioactive molecules, and cells are combined and
assembled to manufacture complex engineered structures
for biological studies with particular interest for regenera-
tive medicine.2,3 To date, there are four main strategies for
bioprinting: extrusion-based (also referred to as bioplotting),
drop-based (also referred to as inkjet or drop-on-demand),
laser-based bioprinting (also known as laser-induced for-
ward transfer [LIFT]), and SLA.16,17 Each of these tech-
niques shows different ranges of resolution, manufacturing
times, and limitations (extensively reviewed elsewhere3,17).
Biomaterials Used in Bioprinting
Biomaterials can be categorized regarding their source,
from either natural or synthetic sources, and are grouped
into static (nondegradable) and dynamic (biodegradable,
through hydrolysis or enzymatic degradation). Materials
used in biofabrication must meet specific criteria, depending
on the fabrication technique (comprehensively reviewed in
Moroni et al.2). Historically, materials used in bioprinting
are those that quickly stabilize from nonviscous states18,19
and can mainly be divided into hydrogels (reviewed in
Gungor-Ozkerim et al., Bishop et al.20,21) and microcarriers
(reviewed in Ashammakhi et al.22). To be suitable for ex-
trusion bioprinting (the most commonly used biofabrication
technique), a material must show steady flow until deposi-
tion and must rapidly stabilize upon delivery.
Scaffold-Free Approach in Bioprinting
In addition to scaffold-based bioprinting approaches,
the so-called scaffold-free bioprinting technique has also
emerged in the last decade. This consists in the use of cells
or cell aggregates, without any support material for the bio-
printing process. Therefore, providing a natural environment
for cells promotes better cell/cell interaction, compared with
the traditional 3D printing techniques. This technique may
be of particular interest for induced pluripotent stem cells
(iPSCs), until the discovery of new hydrogels that can better
maintain iPSC viability and differentiation state.
3D Bioprinting Strategies—Nozzle-Based
Bioprinting Techniques
In vitro 3D models are of great advantage to investigate
the safety and efficacy of several therapeutic agents for drug
development and screening and to model dynamic biologi-
cal processes. Numerous normal and diseased 3D tissue
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models have been developed and extensively reviewed
elsewhere. Therefore, here we aim to explore the most re-
cent findings in the last year on bioprinted in vitro tissue
models and their potential applications.
Vascular Tissues
An extensive review stating materials, cells, and tech-
niques used in bioprinting approaches with particular focus
on vascular structures has been published elsewhere.17 In a
breakthrough study, Attalla et al. presented a new micro-
fluidic nozzle design capable of multiaxial extrusion to 3D
print and pattern bi- and trilayered hollow channel struc-
tures. These nozzles allow for the structures to be embedded
within layers of gels and ECM proteins in a quick and
simple manner. Their design allows for multiaxial extrusion
and wide versatility in material incorporation to create
heterogeneous structures.23 These highly complex hetero-
geneous and hierarchical architectures show great potential
applications on artificially fabricated tubular or fiber-like
structures, including vascular and nervous tissue applica-
tions. In a recent study, xanthan gum was deposited into a
CaCl2-infused gelatin to form sacrificial channels to rapid
prototype microfluidic platforms with earlobe-shaped chan-
nels.24 Using this method, the authors created complex 3D
structures, stable enough to support themselves as well as
complex channel geometries that were evenly perfusable.24
To further develop potential new vascular tissues, Ji et al.
deposited a sacrificial ink between several layers of a
cell-laden oriented hydrogel bioink to therefore produce
perfusable channels. Briefly, they constructed methacrylate
alginate or methacrylate hyaluronic acid hydrogels with
incorporated sacrificial ink (Pluronic), which was removed
after curing. Mesenchymal stromal cells (MSCs) were in-
cluded in the bioprinted matrix hydrogel and showed high
viability, and endothelial cells (ECs) were perfused inside
the channel, attaching inside the channels circumferentially
to form confluent layers. The novelty of this method arises
from the fact that the sacrificial ink and the matrix hydrogel
were not mixed during the deposition process, which al-
lowed for high resolution of the final channel after per-
fusion.25 With this approach, the authors have produced
tunable channels with a large range of sizes (300 to 1500mm
in diameter) and complexities, including a matrix with con-
verged channels, without complex device modifications for
bioprinters nor complicated methods for ink synthesis and
processing as previously reported.26
Schöneberg et al. used drop-based bioprinting to gener-
ate in vitro blood vessel models. They separately deposited
droplets of gelatin with ECs to form the core of the struc-
ture, followed by a layer of fibrinogen with smooth muscle
cells, and an external layer of thrombin. This approach al-
lowed for the crosslinking of the fibrinogen and the external
thrombin to form an outer fibrin layer to surround the core
material. Once completed the process, a collagen/fibrinogen
based bioink containing fibroblasts was quickly crosslinked
with thrombin. By doing so, the authors successfully re-
produced the three layers of a blood vessel by reconstituting
the tunica intima (endothelium), tunica media (elastic smooth
muscle cells), and the tunica adventitia (matrix of fibro-
blasts).27 Additional work is still needed to engineer de novo
vascular tissues, although the novel technique developed by
Schöneberg et al. is a valuable step forward in that direction
as they achieved to manufacture perfusable vessel models
with a biofunctional multilayer wall composition.
Neural Tissue
The complex physiology and the limited regenerative
capacity of the neural tissue make the repair of this system
extremely challenging. However, recent studies have uti-
lized bioprinting techniques to seek for viable approaches.
Extensive reviews on engineering 3D environments to in-
crease neural cell viability28 and to recapitulate in vitro
disease models of the central nervous system29 have recently
been published. A promising study for disease modeling and
spinal cord nervous tissue regeneration has been published
by Joung et al. They first generated oligodendrocyte pro-
genitor cells (OPCs) and spinal neuronal progenitor cells
(SNPCs) from iPSCs. These two cell types were sepa-
rately incorporated as clusters of either OPCs or SNPCs into
precise positions within a biocompatible scaffold (made
either of acetoxy-based vulcanizing silicone, poly(ethylene
glycol) diacrylate, or hydrogels of alginate mixed with
methylcellulose at different ratios). Successful bioprinting
of OPC clusters in combination with SNPCs resulted in
outgrowth of axons and associated OPCs, suggesting that
SNPCs could successfully differentiate into mature neu-
rons, and OPCs into oligodendrocytes to myelinate the ax-
ons.30 These constructs showed to be a suitable multicellular
neural tissue engineering approach to model the complex
central nervous system tissue architectures in vitro.
Ning et al. have used composite hydrogels of alginate,
fibrin, hyaluronic acid, and arginylglycylaspartic acid (RGD)
peptides encapsulated with Schwann cells to construct
scaffolds with potential to repair nerves after injury.31 They
have shown that Schwann cells were viable, proliferated,
and aligned inside the hydrogels, therefore providing ade-
quate cues to direct the extension of dorsal root ganglion
neurites along the bioprinted strands.
Skin
Several approaches have been developed in the last year
to manufacture skin-like substitutes as grafts to quickly re-
established its structure and function upon injury. Miguel
et al. have combined electrospinning and bioprinting
techniques to manufacture 3D skin construct mimics. A
poly(caprolactone) and silk sericin blend was electrospun
to produce a mimic of the epidermis, while the dermis layer
was formed by depositing layer-by-layer a chitosan/alginate
hydrogel. The results revealed constructs that displayed
morphology, porosity, mechanical properties, wettability,
and antimicrobial activity that grants their application as
potential skin substitutes. In addition, these structures were
incubated with fibroblasts (normal human dermal fibroblast
[NHDF] cell line) and showed to support cell adhesion,
migration, and proliferation.32 Together, the results showed
that the top electrospun layer can act as protective barrier
against microorganisms’ infiltration, while the porous hy-
drogel constitutes a suitable structure for cell migration and
proliferation.
Using a composite hydrogel of alginate and gelatin,
Liu et al. have also developed bioprinted structures with
promising potentials for future skin tissue engineering.33
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Human epithelial cells and MSCs were bioprinted to form
bilayered skin-like constructs of epidermis and the stro-
mal layers in vitro, respectively. These constructs showed
that rheological properties commensurate with their po-
tential applications, including shear-thinning behavior and
temperature-dependent viscosities, and support high cell
viability. Similar studies were later performed by Cheng
et al.,34 however, alginate/gelatin-based bioinks were used
to induce the differentiation of epidermal progenitors toward
sweat gland-like cells They showed that MSCs injected on
the alginate/gelatin-based bioink differentiate sweat gland-
like cells expressing their keratin-associated markers after
7 days. In addition, the stiffness of the bioink showed to be
similar to that of the mouse dermal tissue.
Derr et al. have manufactured a fully 3D bioprinted skin
equivalent using a three-syringe configuration to extrude
three independent solutions. To mimic the dermis, they
prepared a hydrogel containing gelatin, fibrinogen, collagen
type I, and elastin incorporated with fibroblasts, the basal
layer mimic was composed of an acellular solution of laminin/
entactin, and the epidermis composed of solely keratocytes
in the culture media. This bioprinted skin equivalent showed
good barrier function, high cell viability, and morphologi-
cally, features similar to those of normal human skin, as
given in Derr et al.35
Atala’s group developed a novel approach, coined ‘‘Bio-
Mask.’’ This is a customized engineered skin substitute
combined with a wound dressing layer that fits onto the
facial wound. Using computed tomography images of skin
wounds in mice, they precisely dispensed dressing mate-
rial and cell-laden hydrogels into the wound in a layer-
by-layer manner (Fig. 1A). The manufactured BioMask
consisted of three layers: (1) a porous polyurethane layer,
(2) a keratinocyte-laden hydrogel (hyaluronic acid, glyc-
erol, gelatin, and fibrinogen) layer, and (3) a fibroblast-laden
hydrogel (hyaluronic acid, glycerol, gelatin, and fibrinogen)
layer. The 3D BioMask was then placed on a wound site
previously implanted with a cartilage-like structure made
of poly(e-caprolactone) on athymic mice models (Fig. 1B).
The in vivo results showed skin contraction, and the histo-
logical examination revealed the regeneration of skin tis-
sue consisting of epidermis and dermis layers.36 The same
FIG. 1. BioMask implantation. (A) Illustration of skin wound animal model creation and implantation of a predesigned
face-shaped architecture. (B) Surgical application of the BioMask. Wound contraction measurement, a reduction on 50%
( p < 0.05) of the wound area was observed when the BioMask was implemented. Adapted with permission from Seol et al.36
Color images are available online.
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group used in situ bioprinting of autologous skin cells to
promote wound healing of full-thickness wounds in murine
and porcine models. After excision, full-thickness wounds
were covered with a layer of human fibroblasts followed
by a layer of human keratinocytes, both suspended in a
fibrinogen/collagen-based solution. Excisional wounds showed
quick wound closure, diminished contraction, and accel-
erated re-epithelialization. The regenerated tissue showed
commensurate dermal structures and composition similar
to that of healthy skin, with extensive mature vascular for-
mation, proliferating keratinocytes, and high collagen de-
position in a highly arranged manner.37
Apelgren et al. manufactured bioprinted constructs using
nanofibrillated cellulose/alginate bioinks mixed with MSCs
and adult chondrocytes that were implanted in a subcu-
taneous pocket in the back of nude mice models. After
45 days, the back-skin pockets were opened, and a full-
thickness skin allograft was transplanted and fixated onto
the 3D biofabricated constructs using Prolene sutures. After
60 days, the pocket roof was removed, and the surrounding
skin was sutured edge-to-edge to the transplanted skin cov-
ering the 3D-printed construct for extra 15 days and engrafted
without any macroscopic signs of necrosis or detachment.
The results showed that the bioprinted cartilage constructs
supported the transplanted skin with nutrients and oxy-
gen delivery,38 suggesting that the cartilage bioengineered
construct serves as a bed for a full-thickness skin grafts.
This approach allows to create a novel 3D setup with po-
tential use on clinical situations when the patient has the
need for the reconstruction of composite structures, such as
auricular tissues.
Liver
In late 2018, Mazzocchi et al. combined collagen type-I
and hyaluronan (in a ratio of 3:1) to formulate a hybrid
bioink to bioprint liver tissue. When cultured with primary
human hepatocytes and stellate cells, the tissue showed to be
physiologically relevant. The cells maintain their normal
urea and albumin production and respond appropriately to
acetaminophen (being damaged upon overdosing) for a pe-
riod of 2 weeks.39 To further develop and optimize liver-
on-a-chip devices, Christoffersson et al. have developed a
modified hydrogel embedded with hepatocytes derived from
human pluripotent stem cell-derived hepatocytes (hiPS-HEPs).
Briefly, they modified hyaluronan and poly(ethylene glycol)
hydrogels with cyclic RGD peptides in a perfused chip
device to promote the growth, migration, and albumin and
urea production of the hiPS-HEPs.40
Heart
Wang et al. have recently assessed the functional prop-
erties of the in vitro cardiac tissue model previously de-
veloped by the Lewis group.41 Briefly, constructs were made
of a fibrin-based cell-laden hydrogel (printed together with
rat ventricular cardiomyocytes), a gelatin-based sacrificial
hydrogel, and poly(e-caprolactone). They have characterized
the cardiac cell synchronization, beating behavior, electro-
physiological properties, and contractile force measurement
of such constructs and showed a new strategy to bioengineer
functional contractile cardiac tissue. These constructs pos-
sessed a highly organized structure with the unique physi-
ological and biomechanical properties of the native cardiac
tissue and exhibited physiologic responses to known cardiac
drugs regarding beating frequency and contraction forces.42
Noor et al. used an omental tissue biopsy to extract
stromal cells and to develop decellularized bioprinted per-
fusable cardiac patches that entirely match the immuno-
logical, cellular, biochemical, and anatomical properties of
the patient.43 The extracted omental cells were reprogrammed
into iPSCs and subsequently differentiated into either car-
diomyocytes or ECs. Using the previously described sup-
porting medium method44 composed of sodium alginate,
xanthan gum, and calcium carbonate, they were able to
bioprint functional vascularized patches modeled after the
patient’s anatomy with elongated cardiomyocytes with ac-
tinin striation.43
Feinberg’s group has recently published an update of the
original version of their freeform reversible embedding of
suspended hydrogels (FRESH) v1.0 approach, where the
authors have engineered 3D collagenous components of the
human heart at various scales, ranging from capillaries to
the whole organ.45 One of the biggest advantages of the
FRESH v2.0 is the improved resolution by one order of
magnitude, with reliable collagen filaments printed from
200 to 20mm in diameter. The authors developed a porous
microstructure to enable rapid cellular infiltration and mi-
crovascularization (due to vascular endothelial growth fac-
tor [VEGF] incorporation on the bioink), a structure with
mechanical strength suitable for the fabrication and perfu-
sion of multiscale vasculature and trileaflet valves. When
printed with human embryonic stem cell-derived cardiomyo-
cytes and cardiac fibroblasts, the ‘‘artificial’’ cardiac ventricle
showed synchronized contractions, immunofluorescent stain-
ing of sarcomeric a-actinin-positive myofibrils, directional
action potential propagation, and wall thickening of up to
14% during peak systole mimicking the hallmarks events
occurring in health. In addition, they bioprinted whole neo-
natal human heart that accurately reproduced the anatomical
patient-specific features, including the atrial and ventricular
chambers, trabeculae, and pulmonary and aortic valves.
In addition to heart models, others have developed mi-
crofluidic stroke models with an oxygen scavenging biochip
material in combination with integrated opto-chemical ox-
ygen sensing microbeads. These constructs were used to
recreate the desired reduced oxygen concentrations and
therefore mimic the in vivo conditions during ischemic
stroke.46 Precise control over oxygen scavenging rates was
achieved by variations in material curing protocols (tem-
peratures and curing times), microfluidic layout (higher area
to volume aspect ratios), and flow rates.46
A recent report has utilized a scaffold-free approach to
create tubular cardiac constructs from bioprinted spheroids
of clusters formed of iPSC-derived cardiomyocytes, fibro-
blasts, and ECs.47 The authors observed spheroid fusion and
beating while still on the needle array. A bioprinter was used
to assemble the cardiac spheroids into scaffold-free cardiac
constructs, which showed cellular reorganization (troponin
T-positive cells on the outer layer of the constructs and
CD31-positive cells on the inner regions of the constructs)
that may mimic that observed during organ transplantation.
This approach is a forward step to overcome the problem
of host’s immune response to artificial materials, which is a
major challenge in cardiac tissue engineering.
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The Lewis group reported a novel biomanufacturing ap-
proach named sacrificial writing into functional tissue
(SWIFT) that allowed for the manufacturing of organ-
specific tissues with high cellular densities. The authors
used this method to create perfusable vascular channels. To
achieve so, they used patient-specific iPSC-derived orga-
noids as ‘‘organ building blocks’’ (embryoid bodies, cere-
bral organoids, and cardiac spheroids) that were suspended
and placed into a collagen-based ECM solution. These
structures were thereafter compacted and a sacrificial ink
(gelatin-based) written to create the vascularized structures.
The results showed that the approach does not affect the
intricate microarchitecture of either structure. To further
explore this approach, the authors created a functional per-
fusable cardiac tissue with high cell density composed
of organ building blocks of iPSC-derived cells mixed with
dermal fibroblasts and the collagen-based ECM. When
formed into a small disc-shaped mold, this construct started
to beat spontaneously and synchronously with calcium waves
that propagate rhythmically and rapidly throughout the tis-
sue. This architecture was then perfused, and over an 8-day
period, it developed a pervasive sarcomeric configuration
with increased contractility and beating synchronization.
Moreover, the authors printed an arterial vascular network
geometry within the cardiac organ building blocks matrix,
using patient-specific structural data, to accurately replicate
the geometry of the left anterior descending coronary artery.48
This thorough study opens new windows to create person-
alized patient- and organ-specific structures with vascular
architectures.
Kidney
Pitsalidis et al. demonstrated recently in a proof-of-principle
study that conducting polymers can be used not only as
alternative electrode materials but also as electrochemical
transistors and simultaneously maintain their scaffolding
functions. They demonstrated how an engineered 3D tubular-
like system can be used to create a 3D cell culture com-
partment for barrier integrity studies of 2D kidney barriers
under flow conditions.49 Using epithelial kidney cells and
human fibroblasts cultured on macroporous scaffolds with
tuneable properties, the authors showed that cells grow
quickly to form tissue-like architectures within the con-
ducting polymer scaffold that constitutes the channel of the
transistor. The tissue formation inside the conducting
polymer channel progressively modulates the transistor
characteristics (configuration). By monitoring the real-time
changes in the steady-state characteristics of the transistor
with the growth of the cultured tissue, the authors obtained
valuable insights on the transients of tissue formation.
Moreover, this approach enables label-free, dynamic, and in
situ measurements for real-time tracking of 3D cell cultures
and compatibility with potential use in long-term organ-on-
chip platforms.
To provide a tissue-specific microenvironment for renal
tissue formation, Ali and Pr have bioengineered an ECM-
derived hydrogel using decellularized porcine whole kid-
neys dissolved in acidic solutions and chemically modified
by methacrylation. When bioprinted with human renal cells,
these structures showed high cell viability, proliferation, and
more importantly, cell maturation (into proximal and distal
tubular cells and podocytes). When compared with the na-
tive renal structures, the artificial architectures showed
similar structural (including the formation of tubular and
glomerular-like structures) and functional characteristics
(electrolyte reabsorption and aminoacid transportation ac-
tivity).50 The authors are currently performing animal model
investigations to further characterize this model regarding
its interactions with the host tissue.
Skeletal Muscle
Kim et al. have used a decellularized porcine skele-
tal muscle tissue as bioink to bioengineer skeletal muscle
tissues. The authors modified the decellularized tissue via
methacrylation to enhance its mechanical stability and com-
bined it with fibrillated polyvinyl alcohol. Using a previously
developed bioprinting method,51 the authors fabricated uni-
axially aligned fibrillated micropatterned structures. When
laden into this architecture, myoblasts were highly aligned
with accelerated myogenic differentiated and high degree
of myotube formation.52 The same group has modified the
previous decellularized matrix structures with poly(lactide-
co-glycolide) (PLGA) to fabricate a multiscale composite
scaffold of aligned electrospun ECM fibers and 3D-printed
fibrillated PLGA. These composite structures were used to
promote aligned cell orientation, differentiation, and myo-
tube formation of human muscle progenitor cells while
providing a nanosized basal lamina of ECM.53 These two
strategies show great potential for applications on muscu-
loskeletal tissue constructs, including tendons and ligaments.
In addition, the same group has bioengineered skeletal muscle
constructs that showed promising results on muscle function
restoration. Briefly, they fabricated a construct composed of
a sacrificial acellular bioink, a supporting polycaprolactone
pillar, and a fibrinogen/gelatin-based bioink laden with hu-
man progenitor cells. The bioprinted tissue showed highly
organized multilayered muscle bundles composed of viable,
highly packed, and aligned myofiber-like structures. When
implanted into rat models with tibialis anterior defects, the
constructs showed good integration with the host vascular
and neural networks that result in the restoration of muscle
formation.54
Cartilage
Cartilage damage is often accompanied with subchondral
bone injuries. Therefore, the construction of novel scaffolds
that support both cartilage and subchondral bone regenera-
tion appears to be of crucial importance. Li et al. answer
that call by coating polycaprolactone scaffolds with a self-
assembling peptide hydrogel to promote the proliferation
and osteogenic differentiation of rabbit bone MSC and main-
tain the chondrocyte phenotype.55 When implanted in vivo,
these structures induced simultaneous regeneration of car-
tilage and subchondral bone.
Multicellular spheroids of chondrocytes, ECs, and MSCs
were bioprinted in a scaffold-free approach to generate ar-
tificial tracheas. These were matured in a bioreactor for
28 days and then transplanted into rat animal models as a
tracheal graft. The bioprinted artificial trachea showed suf-
ficient mechanical strength to be transplanted into the tra-
chea of rat models, with chondrogenesis and vasculogenesis
being observed as soon as 8 days post-transplantation.56
96 RAMOS AND MORONI
D
ow
nl
oa
de
d 
by
 U
N
IV
 O
F 
M
A
A
ST
R
IC
H
T
 f
ro
m
 w
w
w
.li
eb
er
tp
ub
.c
om
 a
t 0
8/
11
/2
0.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
Several strategies have been recently developed to in-
crease the viability of chondrocytes. Mekhileri et al. have
developed a two-step approach to achieve enhanced cell
viability by constructing a bioassembly system that con-
sisted of a fluidic-based singularization and injection module
incorporated into a 3D bioprinter apparatus. This singular-
ization device collects the pooled microtissues from the
high-throughput fabrication process to then deliver indi-
vidual microtissues to an injection module that allows for
their insertion into precise locations within a 3D-plotted
scaffold. This method was used to fabricate bilayered con-
structs by alternatively depositing a thermoplastic poly-
mer solution and inserting predifferentiated chondrogenic
microtissues or cell-laden gelatin-based microspheres.57 In
addition to long-term chondrocyte viability, these constructs
also showed deposition of cartilage-specific ECM proteins,
and clinically relevant shape and size. The flexibility of
this approach could also be used to pick and place cellular
spheroids in a priori designed locations and used to study
specific pathological conditions in a 3D in vitro model
system.
Malda’s group has bioengineered microfiber-reinforced
hydrogels that simultaneously capture the zonal depth-
dependent mechanical properties of native cartilage and
support neocartilage formation.58 By combining melt
electrospinning of poly(e-caprolactone) with a gelatin-
methacrylamide hydrogel, the authors developed a bilayered
microfiber architecture of a densely distributed crossed fiber
mat (superficial tangential zone) to improve the load-bearing
properties of the construct and a uniform box structure
(middle and deep zone). The acellular composite structure
showed a stress relaxation response comparable with the
tested native cartilage, and when cultured with chondrocytes
under mechanical conditioning, significant production of
sulfated glycosaminoglycans and collagen type II was ob-
served. For the first time, the authors showed the importance
of incorporating a viable superficial tangential zone in ar-
ticular cartilage tissue engineering (TE) applications.
Bone
Bone defect repairs are still challenging clinical problems
in musculoskeletal systems. Lai et al. have addressed these
problems by developing a novel porous scaffold composed
of magnesium, poly (lactide-co-glycolide), and b-tricalcium
phosphate. These were deposited using low-temperature AM
and transplanted into rabbit models with femora condyle
defects. At 12 weeks postsurgery, histological and mechan-
ical properties were assessed, and a significant new bone
formation and newly formed vessels with well-architected
structure were observed. In addition, these constructs showed
well-designed biomimic structures and improved mechanical
properties, making them a promising composite biomaterial
for repairing challenging bone defects.59
Graphene oxide was used to improve the structural sta-
bility and osteogenic properties of alginate-based bioinks.
Choe et al. used such composites bioprinted with MSCs to
enhance their osteogenic differentiation.60
To efficiently promote osteogenic differentiation of adult
stem cells, Wei et al. developed silk fibroin-based 3D-
bioprinted composite (together with gelatin, hyaluronic acid,
and tricalcium phosphate) coated with human platelet-rich
plasma.61 Human adipose-derived MSCs cultured on such
structures significantly upregulated the gene expression levels
of late osteogenic markers and showed enhanced growth
and proliferation profiles. This showed to be a more efficient
approach to drive osteogenic differentiation of adult stem
cells with potential applications for bone TE.
The variety of materials combined with the low costs
associated with extrusion-assisted bioprinting (reviewed re-
cently by Miri et al.62) has made it the primary choice to
fabricate bioprinted microfluidic platforms. However, the
resolution is limited to roughly 30–100 mm for the cur-
rent bioink systems, and therefore, optical-based techniques
have been developed to provide better resolutions.
Other Biofabrication Techniques—Optical-Based
Techniques
In extrusion-assisted AM, a material is dispensed through
an extruder or nozzle while a computerized arm moves the
nozzle to create the 3D shape. Direct extrusion AM of mi-
crochannels can be challenging due to the collapse of the top
layers into the microchannels; therefore, this technique is
often combined with a support material that is removed
postprinting (sacrificial printing). The selective removal of
the sacrificial material leads to a hollow microfluidic system
in the core structure. In addition to extrusion-assisted AM,
recent approaches have focused on light reactions to solidify
the structure and make microchannels with higher resolu-
tion.63 As there are no nozzles being used during fabrica-
tion, clogging is not an issue, so higher viscosity fluids could
be processed, and there is no risk of shear stress-induced cell
damage or phenotype alterations. When compared with the
conventional extrusion-assisted AM, photopatterning shows
higher resolution and better cell viability.64–66 One re-
maining challenge in optical-based bioprinting is the syn-
thesis of a larger palette of hydrogels that can better mimic
the ECM properties, thus interacting more and more with
the encapsulated cells. Here, we classify the optical-based
bioprinting technique to three main technologies: SLA,
LIFT, and two-photon lithography.
Stereolithography
In conventional SLA apparatus, a laser beam raster scans
across the liquid resin or hydrogel solidifying it through a
photochemical reaction.16,67 SLA does not require the use
of expensive molds, which may lead to an efficient com-
mercialization of the organ-on-chip platforms manufactured
using this technique.62 An extensive review on fabricat-
ing tissue scaffolds using photopolymerization with partic-
ular focus on SLA approaches was recently published by
Whittington’s group.67 In a staggering study, Grigoryan and
Paulsen exploited the use of food dyes as photoabsorbers
in photo-crosslinkable hydrogels to increase the resolution
and diminish the light diffusion in their constructs.68 Their
fabricated intravascular and multivascular bioprinted con-
structs, perfused with red blood cells, showed capacity for
oxygenation and functionality in vivo in a hepatic model.
However, the photo-crosslinkable hydrogel itself was not
loaded directly with cells during fabrication. By doing so,
they reduced the light diffusion during the process, in-
creasing the resolution and the complexity of the final con-
struct.68 As a result, they could fabricate intricate structures
TERM 2019: THE ROLE OF BIOFABRICATION—A YEAR IN REVIEW 97
D
ow
nl
oa
de
d 
by
 U
N
IV
 O
F 
M
A
A
ST
R
IC
H
T
 f
ro
m
 w
w
w
.li
eb
er
tp
ub
.c
om
 a
t 0
8/
11
/2
0.
 F
or
 p
er
so
na
l u
se
 o
nl
y.
 
to study the oxygenation of red blood cells in an alveolar-
like vascular network. These vascular structures were used
to explore the oxygenation of alveolar airways and chronic
liver injuries.
Grix et al. fabricated liver equivalents for advanced
organ-on-a-chip applications using SLA with two bioinks
based on gelatin and polyethylene glycol. Briefly, they
fabricated hexagonal constructs with 12 hollow channels to
allow for perfusion of complete organoids. These constructs
were incorporated with HepaRG cells (cells able to differ-
entiate toward the biliary-like and hepatocyte-like pheno-
type) and human hepatic stellate cells. The bioprinted liver
tissue equivalents were found to have high albumin and
cytochrome P450 3A4 (a liver enzyme) expression, tight
junction protein ZO-1 and MRP2 (a liver-specific bile
transporter multidrug resistance-associated protein 2) ex-
pression, and the overall metabolism remained stable with
normal levels of glucose, lactate, and lactate dehydrogenase
production.69
Parrish et al. have used SLA to construct a dual perfu-
sion microphysiological bioreactor platform into a 96-well
plate to support a large number of samples and recreate the
parenchymal barrier tissue constructs, while maintaining
sample addressability and compatibility. Using such ap-
proaches, they developed a (1) novel perfused biofabricated
3D ovarian cancer spheroid model with anticancer drug
screening capabilities and (2) a perfused bioprinted vascular
coculture model of human umbilical vein endothelial cells
(HUVECs) and bone marrow-derived MSCs. In addition,
these constructs showed the capacity to support nonde-
structive quantitative computed tomography imaging for
soft and hard tissue.70
Huebsch et al. developed a heart-on-a-chip device for
metabolically driven maturation of human iPSC (hiPSC)-
derived cardiomyocytes. They constructed polydimethylsiloxane
(PDMS) devices using two-step photolithography to build a
3D cardiac microphysiological system to improve imme-
diate microtissue alignment and tissue-specific ECM pro-
duction. Through the 3D structures, cells showed changes
regarding their electrophysiology and pharmacology, which
were not observed in the 2D monolayer models of the same
cell type. Cell contraction was measured via PDMS mi-
cropillar deformation and correlated with gene expression to
observe the systematic combination of biophysical stimuli
and metabolic cues, and therefore improve the electro-
physiological maturation of hiPSC-derived cardiomyo-
cytes.71 Following similar approaches, Caluori et al. have
combined an electrochemical multielectrode array with
atomic force microscopy measurements to record the beating
rates of cardiomyocyte organoids together with the defor-
mation of the cardiac cluster during contraction following
effects of heart drugs.72
To improve the outcomes from bioprinted muscle equiv-
alents, Shima et al. have developed a stretchable culture
system for muscle-like constructs. Briefly, molds for the
culture stages, stamps, and anchors were fabricated by SLA
using PDMS, and myocytes laden into a collagen/Matrigel-
based bioink. After plating, the hydrogel containing myo-
cytes was molded with the PDMS stamp and posteriorly
fixed using anchors. These structures were either left
unstimulated or electrically stimulated to induce muscle
contraction. The authors observed the formation of multi-
nucleated myotubes with sarcomere formation and inter-
cellular calcium transfer, necessary for muscle contraction.
Despite showing spontaneous contraction on nonstimulated
structures, it appears sporadically and not synchronized in
the tissue. When electrically stimulated, a second interval
contraction rate was detected.73 These architectures pave
new routes for new insights on basic biology research and
drug screening for skeletal muscle TE applications.
Volumetric Bioprinting
The scalability of AM techniques is limited by their
printing velocity since lengthy biofabrication processes may
impair cell viability and proliferation. To overcome these
limitations, Bernal et al. have bioprinted clinically relevant
sized and anatomically shaped structures in a matter of tens
of seconds by using volumetric bioprinting. Using gelatin-
based photoresponsive hydrogels and optical-tomography-
inspired printing approaches (digital light projection printing
using digital micromirror devices), the authors have created
living tissue constructs of a human auricle (Fig. 2) and
trabecular bone models that promote high cell viability. In
addition, the volumetric bioprinting structures showed artifact-
free surface features, reproducing more faithfully the sur-
face features of the model particularly when compared with
other AM approaches (Fig. 2D), and the possibility to bio-
print free-floating parts without the need for sacrificial ink
support materials to therefore generate structures that can
reversibly modify their shape postprinting as often applied
in 4D bioprinting.74 The authors reported a novel biofabri-
cation strategy to rapidly create large structures that can be
potentially loaded with high cell numbers for regenerative
medicine applications.
Laser-Assisted Bioprinting or LIFT
Recent studies have shown that this technique is the least
productive regarding the volume of bioprinted material
per minute. In addition, the preparation of samples is costly
and demanding. It also requires extremely high percentages
of relative humidity in the bioprinter enclosure to counter
effect cell dehydration.75 This approach, on the contrary,
makes it possible to manufacture structures with cell-level
resolutions, and the bioink can be loaded with cell densities
comparable with those observed on living tissues.76
In an innovative approach, Kérourédan et al. combined
endothelial progenitor cells (EPCs) with stem cells from the
apical papilla (SCAPs) as osteoprogenitors to promote bone
formation and induce the formation of a vascular network.
They deposited specific high cell density patterns of EPCs,
using laser-assisted bioprinting onto a collagen hydrogel
previously cultured with SCAPs. They observed the for-
mation of capillary-like networks at day 6.77 On a follow-up
study using murine models, the same group investigated
the deposition of ECs in situ in calvaria defects to promote
bone regeneration.78 The bone calvaria defects were pre-
filled with collagen hydrogels preloaded with MSCs prior
the deposition of a specific EC pattern. They observed, 2
months postimplantation, significantly higher rates of vas-
cularization and bone regeneration when ECs are cultured
in specific patterns and densities than when seeding ran-
domly,78 corroborating the importance of patterning on
vascularization and bone regeneration.
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Sorkio et al. have produced three types of human corneal
structures using recombinant human laminin and human
sourced collagen I as the bases for the functional bioinks.79
The stratified corneal epithelium mimicked using human
embryonic stem cells, while the lamellar corneal stroma was
produced by alternating acellular layers of solely bioink and
layers with human adipose tissue-derived stem cells. The
bioprinted cornea-mimicking tissues showed to promote
cell proliferation and viability, morphological features re-
sembling those of the human ocular epithelium, expression
of key markers of differentiated corneal epithelium, and
formed organized corneal stromal-like structures. In addi-
tion, when transplanted into porcine organ cultures, the 3D-
bioprinted stromal structures attached to the host tissue and
histological observations showed migration of the adipose
tissue-derived stem cells into the host corneal stroma. This
is the first study to demonstrate the feasibility of 3D laser-
assisted bioprinting for corneal applications. The same
group has compared the behavior of hiPSCs when these
were laser bioprinted in combination with different bioma-
terials. The authors have suggested that the cells are effec-
tively more sensitive to the applied biomaterials, but not to
laser bioprinting per se, regarding their viability, prolifera-
tion, and differentiation potential.80 The results showed that
the combination of bioprinted hiPSCs with hyaluronic acid
with pluripotency supporting cell culture medium on Ma-
trigel allowed the generation of precise predefined hiPSC
patterns that maintain their pluripotency and differentiation
potential. This is the first successful approach to bioprint
hiPSCs by laser-based techniques, with huge potential to be
applied when highly controlled bioprinted patterns without
interfering with cell pluripotency are required.
Kim et al. have created a silk fibroin-based bioink by
a methacrylation process for digital light processing. These
fibroin-based hydrogels showed outstanding mechanical,
rheological (constant storage and loss modulus upon shear
strain), and cytocompatibility properties that are adequate
for experimental testing with potential application in various
TE structures. When incorporated with human chondrocytes
and bioprinted into a trachea-like shape, these architectures
showed cartilage-like features, including cell organization
and a matrix rich in proteoglycans and collagen.81 This
approach showed the potential applications for a naturally
occurring polymer to be used as bioink with equivalent
strength and stability properties when compared with most
common alternatives, which are often combinations of nat-
ural and synthetic materials.
Two-Photon Polymerization
2-PP is a lithography-based AM technique that enables
the biofabrication of structures with submicrometer reso-
lution.82 An extensive review on materials, techniques, and
appropriate geometries to establish a conceptual framework
to engineer biological constructs with 2-PP has been re-
cently published elsewhere.83 Pennacchio et al. have fabri-
cated instructive gelatin-based building blocks using 2-PP
for the production of anisotropic collagen microtissues in
bottom/up tissue engineering. The linear topography strongly
enhanced cell alignment and production of oriented collagen
fibers into highly anisotropic microtissues.84
Ovsianikov’s group has, over the last year (or so), pro-
vided valuable developments on 2-PP technology.85 Using a
gelatin-norbornene-based bioink, previously developed by
the same group in Van Hoorick et al.,86 embedded with
fibroblasts, the authors showed that these constructs had
outstanding biocompatibility, supported cell adhesion, mi-
gration, and proliferation. In addition, the direct embedding
of cells into the porous scaffold provided a uniform cell
distribution and high cell loading capacity independently
of the pore size.82 This was the first study that showed the
possibility of producing cell-embedding hydrogel constructs
manufactured by 2-PP technologies, paving the way to new
high-resolution bioprinting.
Laser-Induced Hydrogel Degradation
One of the biggest challenges when generating large
constructs for TE is the ability to recapitulate the dense
and complex in vivo vascular networks. To overcome this
problem, Slater’s group has developed an image-guided,
laser-induced hydrogel degradation approach that uses syn-
thetic networks or 3D image stacks of in vivo vasculature as
FIG. 2. Volumetric bioprinting process.
(A) The cell-laden reservoir is connected to
a rotating platform, (B) tomographic pro-
jections of the human auricle model, and (C)
resulting printed architecture. (D) Compar-
ison of the surface features of the fabricated
auricle through volumetric printing,
extrusion-based printing, and digital light
processing (scale bar: 500 mm). Adapted
from Bernal et al.74 Color images are
available online.
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templates to fabricate complex microvascular networks.87 In
a follow-up study, the same group has developed an auto-
mated method to design synthetic augmented channels to
enforce controlled flow properties within the 3D networks.
Using computational fluid dynamics methods, they dem-
onstrated flow predictability that closely matches the ex-
perimental results,88 opening a new door to create complex
networks that mimic the in vivo counterparts.
4D Bioprinting—A New Direction
The recent advancements in the fields of microfluidic and
tissue engineering have opened the doors to design and
construct new in vivo models of several diseases. Despite
attracting a great deal of attention, several limitations are
found in 3D bioprinting technologies. Remaining challenges
include the ability to fabricate proper hollow constructs,89 to
develop functional tissue vascular constructs with multiscale
vasculatures,90 and to provide the adequate microenviron-
ment for cell growth, proliferation, and differentiation in
thick 3D structures.90 When time enters the equation of 3D
bioprinting as the 4D, the shapes and functionalities of the
bioprinted constructs can change over time under external
triggering, leading to the arise of 4D bioprinting.91 Broadly,
4D bioprinting includes (1) the deformation of the materi-
als’ shape (conventional or smart materials) and (2) the
maturation of the engineered constructs in a time-dependent
process.91 Although the latter proves to be a promising
strategy to overcome the challenges of 3D bioprinting and
better recapitulate the native tissue,92 it is a general princi-
ple of any tissue engineering process. Hence, 4D bioprinting
is more properly addressed when there is an active time-
dependent change of the biological constructs, which results
in enhanced functionality beyond the conventional tissue
maturation. Therefore, this technology offers the possibility
to create immense varieties of structures with the highest
complexity and resolution.
Shape transformation in 4D biofabrication can be cate-
gorized into three main approaches. The first includes shape
transformation of acellular constructs to then load those
with cells. This is comparable with the traditional scaffold-
based approach, and less-attractive once living cells restrict
the selection on the materials to use and fabrication method.
The second approach includes the deposition of cells onto a
printed construct, and shape transformation of the already
cell-loaded construct, which is an appealing strategy to
provide structural and surface time-dependent instructive-
ness to the seeded cells. The third approach is the fabrication
of a structure with a nonvital material and encapsulation of
cells simultaneously, followed by its shape transformation.
This shows to be a challenging method due to the practical
limitations on controlling cell deposition during the bio-
printing process. Regardless, the latter two approaches have
huge advantages as the shape transformation occurs while
cells have already been incorporated into the construct. The
physical shape transformation can be triggered by various
stimuli, which lead to the shape morphing of the object,
either manually or using the so-called, smart materials with
shape-changing properties.92 These triggering agents can be
categorized into four main approaches: (1) stimuli respon-
sive, (2) spontaneous shape transformation, (3) cell contrac-
tion, and (4) manual transformation.92
Stimuli-responsive processes can be triggered by mois-
ture, temperature, pH, magnetic and electric fields, and
light.90 This approach offers several advantages over the
other methods, as it allows for the precise control of the
moment when shape transformation is needed. It also al-
lows for the folding of multiple objects made of different
materials at multiple scales. Temperature and water sorption
stimulation are the most common shape transformation
factors. Few studies published before 2018 have extensively
addressed these two stimuli approaches.91,93,94
For the first time, Su et al. fully explored the 4D printing
potential of a commercial self-morphing polymer, SU-8,
previously developed by the same group.95,96 They allowed
the polymers deformed temporally to be fixed by vitrifica-
tion or crystallization of the polymer chains, and to return
to their original shape under an external stimulus through
spatial control of the swelling medium (cyclopentanone)
inside the polymer matrix.96 By doing so, the authors cre-
ated passive and active regions within the polymers that
control the self-morphing processes to form different geom-
etries following stimuli. As a proof-of-concept, they showed
that a soft actuator can switch functions to an electrical
circuit. These two studies help paving new routes for the
exploration of other potential candidates, as SU-8 poly-
mer is usually utilized as a photoresist and not designed to
fabricate smart structures for biomedical devices.
With applications on soft tissue injuries, Zhang et al. have
constructed a magnetic-responsive drug delivery dressing
using tetra-PEG/agar hydrogels incorporated with Fe3O4
nanoparticles. In vitro and in vivo drug release studies in
response to changes on the tuned magnetic field showed
better performance of this system when compared with
commercially available ointment systems.97 This magnetic-
responsive hydrogel showed to be a good candidate to im-
prove recovery of injury on soft tissues.
Betsch et al. have also incorporated iron nanoparticles on
printable bioinks to generate complex multilayered tissues.
By applying a straightforward magnetic-based mechanism
in hydrogels during bioprinting, they constructed aligned
collagen fibers using less concentrated hydrogel blends.
Aiming to apply such constructs for cartilage TE, the au-
thors bioprinted constructs with alternated layers of aligned
and random fibers. The cell-loaded constructs with alter-
nating layers of aligned and random fibers expressed sig-
nificantly more collagen II in comparison with the solely
randomly oriented fiber constructs.98 These observations
corroborate the importance of the structural and architec-
tural properties of bioinks used in bioprinting for their use
in tissue engineering applications.
Miao’s group has fabricated biomimetic hierarchical 4D
micropatterns with smart soybean oil epoxidized acrylate
bioinks, using a unique photolithographic-stereolithographic-
tandem strategy. The distinct topographical surfaces of these
bioengineered structures and the external stimulus, delivered
immediately after fabrication printing, effectively regulate
the cardiomyogenic behaviors of human bone marrow MSCs.
The MSCs readily grew and were highly aligned along
the micropatterns, forming uninterrupted cellular sheets.99
Upon external stimuli, a 4D dynamic shape change from 2D
designs into a flower-like structure was observed. The printed
scaffolds also possessed a shape memory effect beyond
the 4D features. A proof-of-concept 4D patch for cardiac
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regeneration was for the first time shown, and the fabricated
patch demonstrated significant cardiomyogenesis poten-
tial suggesting its promising potential for tissue and or-
gan regeneration applications.99 The same group has also
fabricated a 4D anisotropic skeletal muscle tissue using a
‘‘staircase effect’’ strategy and investigated the effects of
topographical cues on the skeletal muscle differentiation of
human bone marrow MSCs.100 Using a layer-by-layer coating
together with a shape memory polymer, smart constructs
exhibiting shape fix and recovery processes were prepared.
The topographical cues of such constructs significantly in-
creased the expression of myogenic genes, suggesting their
application potential for tissue engineering constructs, in-
cluding skeletal muscle. The same group has additionally
developed 4D electroresponsive biomaterials that showed
huge potential for nerve tissue regeneration applications.
Multiresponsive graphene hybrids with 4D-printed archi-
tectures were created, which provided numerous nerve re-
generation characteristics, including physical guidance,
chemical cues, and seamless integration.101 This stimuli-
responsive 4D technique combined with the previous bone
tissue fabrications may pave new ways for repairing bone
defects that are accompanied by nerve damage.
Parameswaran-Thankam et al. have fabricated injectable
thermoresponsive hydrogels of hydroxypropyl guar-graft-
poly(N-vinylcaprolactam) modified with nanohydroxyapatite
with bone tissue engineering applications. The graft copoly-
mer showed excellent thermogelling and injectable properties
suitable for in vitro osteoblast differentiation, controlled drug
delivery of ciprofloxacin, and apatite-like structure forma-
tion.102 Thermoresponsive materials have also been modi-
fied with hyaluronic acid and chitosan to fabricate novel
injectable scaffold with osteoinductive and osteoconductive
activities to support the formation of newly vascularized
bone.103 Briefly, graphene oxide was combined with a ther-
moresponsive hydrogel to support the survival and prolifer-
ation of MSCs and induce the early bone-forming marker
alkaline phosphatase and osteogenic regulator and bone
marker expression by MSCs. When transplanted in vivo
well-mineralized and highly vascularized trabecular bone
was observed. Similar studies were more recently published
by Vojtova et al.,104 where thermoresponsive materials are
further modified to fabricate an injectable hydrogel for bone
tissue regeneration.
Bioassembled In Vitro Tissue Models
As previously mentioned, bioassembly involves the in-
tegration of various-shaped cellular building blocks to re-
construct organomimetic macroscopic cellular tissues. An
extensive review on the different bioassembly techniques
and produced structures has recently been published.2 We
therefore focus solely on the recent research articles pub-
lished in this field.
Layer-by-layer polylactic acid membranes were fabri-
cated by FDM. These constructs were seeded with cocul-
tures of human bone marrow stromal cells and EPCs to
improve vascularization in vivo. Four cellularized mem-
branes were then assembled in a layer-by-layer manner and
early osteoblastic and EC differentiation markers, such as
alkaline phosphatase and von Willebrand factor, were ex-
pressed in all layers of the assembly in a homogenous
manner. When implanted subcutaneously in vivo in mice
models, these constructs showed high degree of vascular-
ization.105 This approach showed to be an efficient method
to obtain a homogenous cell distribution and blood ves-
sel formation within an entire volume of a 3D composite
scaffold.
A novel clamp-shaped micromachine was developed by
Li and Wang using nickel nanoparticles for the indirect
untethered bioassembly of cell-laden micromodules. Using a
multilayer template, the magnetic nanoparticles were mixed
with PDMS for mold replication of the micromachine with
a high-resolution and permeability. The hydrogel micro-
structures (poly(ethylene glycol) diacrylate modified with
RGD peptides) loaded with mouse fibroblasts were effec-
tively assembled into microtissues with precise reconfigur-
able shape and composition. These constructs were modified
to mimic blood vessels, by making a hole in the center of
the micromodule.106 Results showed that indirect mag-
netic manipulation is an efficient and versatile bioassembly
method for cellular micromodules, and the high level of cell
viability makes these structures of potential interest for drug
screening.
Mi et al. have constructed a liver sinusoid on a chip de-
vice using self-assembly of ECs and hepatocytes.107 By
synchronously injecting two kinds of cell-laden collagens,
hepatic-laden and endothelial-laden collagen, they formed
two distinct collagen layers with a clear boundary. This
construct showed high levels of cell viability, and physio-
logical relevant properties in terms of albumin and urea
production. In addition, acetaminophen treatment confirmed
that only a high dose of the drug for a long period would
cause acute liver injury, and a low dose did not lead to an
obvious death of hepatocytes. These results showed that
this liver sinusoid mimic supports hepatocyte viability and
functionality and is beneficial for drug screening.
Flegeau et al. have fabricated a model of kidney glo-
merular barriers using bioassembled podocytes and ECs.108
Briefly, shells of 2% reticulated alginate were formed
around a polycarbonate capillary tube and ECs suspended in
a collagen I solution were injected inside the capillary tube
to form a glomerular microfiber (Fig. 3A-a–c). Podocytes
were dropped onto the fibers to form a glomerular barrier.
These constructs showed high cell viability (Fig. 3A-d) and
expression of specific proteins (including VEGF receptor 2
and von Willebrand factor) (Fig. 3B). More importantly,
they showed ultrastructure similarities to those of human
glomerular barrier.
Conclusion and Future Outlook
AM commercial applications at large are unceasingly
expanding and its market size is expected to reach $10.8
billion by 2021,109 with several companies already working
on bioprinted products for TE applications, including car-
tilage, liver, and bone tissue.110 Here, we have revised the
efforts in the past couple of years to clarify the confusion in
terminology and concepts on biofabrication. We then
highlighted the major evolutions on 3D and 4D bioprinting
of tissues. However, several future developments can be
expected. The biggest drawbacks of large-scale cell-based
therapies are the limited oxygen and nutrient supply to the
innermost parts of the bioprinted structures and the efficient
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waste product elimination. Vascular trees composed of large
vessels and capillaries are then required for the correct
maintenance of large tissues. However, limitations in bio-
printing resolution and speed are still big challenges to
bioprint vascular structure, as the highest resolutions, cur-
rently achievable with laser-based bioprinters, is one order
of magnitude lower than the size of a human capillary.
Therefore, we postulate that the construction of perfusable
branched systems with increasingly smaller microvessels
is of upmost need in a timely manner to prevent tissue
necrosis. Several attempts to enhance angiogenesis on 3D-
bioprinted constructs have been recently reported and ex-
tensively reviewed by Ke and Murphy.111 Despite their
encouraging results, these strategies still need refinement. In
addition to vascular trees, the development of an innervation
network within the constructs is also fundamental for the
normal function of tissues. However, this would be easier
to achieve as it may be inducible using pharmacologic or
growth factor signaling approaches. Regarding the engi-
neering of neural tissues, the main hurdle arises from the
complexity and difficulty of accurately replicating the com-
plex structures of the neurovascular axis. Recent investiga-
tions (although before 2018) have partially tackled this issue
by bioengineering a blood/brain barrier with a high degree of
complexity112 as an example. In addition to the fabrication
of higher complexity structures, functionalization of bioinks
with basal lamina ECM components may also aid on reca-
pitulating the complex cellular responses in neural tissues.
One big challenge in AM is the fabrication of sufficiently
stable and mechanically rigid constructs to ensure successful
transplantation. This is of special concern in hard tissue
applications as the elastic modulus of the bioprinted struc-
tures needs to be high to maintain their physical struc-
ture while maintaining the porosity to support normal cell
growth and viability.
Several studies presented in this review have applied
their bioengineered approaches into in vivo animal models.
However, some have tested their constructs in immuno-
compromised models, which lack the appropriate information
regarding the inflammatory response and foreign body reaction
of the host animal to the artificial constructs. Therefore, im-
planting these structures into preclinical immune-competent
animal models is of upmost need. Prompting the integration
of bioengineered tissues by the host model also assumes a
critical factor for the clinical success of these approaches.
After bioprinting, tissues require maturation for cell as-
sembly and growth. Bioreactors may provide the necessary
maturation factors and other physiological relevant factors
for preimplantation testing of the constructs. The choice on
the correct maturation times, addition of mechanical load-
ing, and cell culture media and its supplements (particularly
the use of animal-derived factors) are urgent issues to be
addressed regarding the potential clinical applications of
these approaches.
Virtually there are no limitations on the choice of poly-
mers to be used in AM approaches, and more studies similar
to the ones of Su et al.96 where a commercial polymer was
used in a completely different context than what originally
designed for, to fabricate smart structures for biomedi-
cal devices, are needed. By applying the same rationale, one
would broaden the possibilities to explore new potential
candidates with applicability on biofabrication. A recurrent
question in bioprinting remains if multiple materials can be
deposited within the same process to further mimic the com-
plex heterogeneity of the living tissues. By doing so, material
gradients, replication of biological interfaces, and vasculari-
zation could all be introduced in one single step. Whether
this can be achieved by extrusion and inkjet bioprinting,
optical-based bioprinting remains limited from this per-
spective. By interconnecting different bioprinted tissues for
drug screening prior to starting clinical trials could even-
tually reduce, or perhaps even eliminate, the use of animal
models. Following the steps of Skylar-Scott et al.,48 we
postulated that by using gene-edited cells derived from the
patients to be laden into 3D structures, one can achieve a
more functional tissue equivalent with closer properties to
those of the native tissue.
As the ‘‘next-generation’’ biofabrication technique, 4D
bioprinting still faces several limitations that remain to be
overcome. The use of biocompatible biomaterials that allow
to obtain high cell density while maintaining the appropriate
rheological properties is still an unmet property of the smart
materials. However, new approaches are now being devel-
oped to meet the desired properties, which include the use of
hybrid structures to respond to multiple stimuli. To closely
mimic the nature of tissues and organs, precise stimulation
methods and high-resolution multimaterial bioprinters are
also necessary.
3D and 4D bioprinting has taken significant leaps in
several technological aspects that are leading TERM to
FIG. 3. (A) The cellularized glomerular
microfiber. (a) The cellularized microfiber
was contained in the shell formed of suc-
cessive layers of reticulate alginate.
Glomerular microfibers kept a similar con-
formation and structure to the native tissue
after (b) 18 h and (c) 5 days upon alginate
shell removal. (d) Endothelial cells show
high viability (scale bar: 500mm). (B) Glo-
merular microfibers showed the expression
of specific endothelial markers at day 14
(immunostaining of (A) PECAM-1, (B)
vWF, (C) Nephrin, (D) Synaptopodin). Blue
arrows show the Weibel-Palade bodies
(scale bar: 50 mm). Adapted from Flegeau
et al.108 Color images are available online.
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higher levels of tissue and organ bioengineering complexity.
Not only faster fabrication of engineered constructs has
been achieved, but structures with high complexities and
resolutions are also being tailored and manufactured. The
success of TERM-based therapies always relies on the de-
velopment of accurate and reliable diagnostic tools based on
the anatomical and physiological characteristics of the pa-
tient. 3D and 4D bioprinting has a large potential to impact
TERM research toward more personalized and accurate
approaches that can be more easily translated into clinic.
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